To examine associations between objectively measured physical activity (PA) and incidence of major mobility disability (MMD) and persistent MMD (PMMD) in older adults in the Lifestyle Interventions and Independence for Elders (LIFE) Study. DESIGN: Prospective cohort of individuals aged 65 and older undergoing structured PA intervention or health education. SETTING: The LIFE Study was a multicenter (eight sites) randomized controlled trial designed to compare the efficacy of a long-term structured PA intervention with that of a health education (HE) program in reducing the incidence of MMD in mobility-limited older adults. PARTICIPANTS: LIFE Study participants (n = 1,590) had a mean ageAEstandard deviation of 78.9 AE 5.2, low levels of PA, and measured mobility-relevant functional impairment at baseline. MEASUREMENTS: Activity data were collected using hip-worn 7-day accelerometers at baseline and 6, 12, and 24 months after randomization to test for associations with incident MMD and PMMD (≥2 consecutive instances of MMD). RESULTS: At baseline, every 30 minutes spent being sedentary (<100 accelerometry counts per minute) was associated with higher rate of subsequent MMD (10%) and PMMD (11%) events. Every 500 steps taken was associated with lower rate of MMD (15%) and PMMD (18%). Similar associations were observed when fitting accelerometry-based PA as a time-dependent variable. CONCLUSION: Accelerometry-based PA levels were strongly associated with MMD and PMMD events in older adults with limited mobility. These results support the importance of daily PA and lower amounts of sedentary time levels in this population and suggest that accelerometry may be a useful tool for assessing risk of mobility disability.
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Key words: accelerometry; mobility disability; physical activity; sedentary time; older adults L oss of the ability to ambulate (mobility) is one of the leading causes of poor quality of life, loss of independence, morbidity, and death in older adults. 1 Preventing mobility loss and the onset of mobility disability is an important public health concern given the rapid aging of the population. 1 Physical activity (PA) is one of the mostpromising interventions to attenuate mobility loss and prevent mobility disability, but individuals at risk of mobility loss are commonly inactive, with evidence indicating that physically inactive individuals tend to be older, less educated, have lower incomes, and have more medical conditions than active individuals. 2, 3 We previously reported that a long-term supervised PA program reduced the risk of incident major mobility disability (MMD), defined as loss of the ability to walk 400 m, by 18% in older adults in the Lifestyle Interventions and Independence for Elders (LIFE) Study. 4 This work demonstrated that a structured PA intervention was efficacious in preserving mobility and preventing MMD in older adults.
Despite this important finding, data remain sparse regarding how gradations in duration and intensity of PA influence the incidence of MMD. The majority of studies using accelerometry have evaluated PA in younger populations 5, 6 or in the evaluation of cardiometabolic health. 7 Furthermore, data are needed regarding the potential utility of device-measured monitoring of PA in a nonlaboratory setting for predicting MMD. We aimed to address these gaps in the literature using accelerometry-measured PA, a noninvasive and objective method of tracking and measuring human PA, 8 gathered in the LIFE Study. To our knowledge, the LIFE Study is the only Phase 3 PA intervention trial with data on the incidence of MMD in older adults. Thus, this study provides a novel opportunity to address questions related to objectively measured PA and associations with MMD.
METHODS

Participants
The LIFE Study was a multicenter randomized controlled trial designed to compare the efficacy of a long-term structured PA intervention with that of a health education (HE) program in reducing the incidence of MMD in mobilitylimited older adults. Sedentary men and women aged 70 to 89 were recruited at eight clinical sites (N = 1,590). Details about specific study design and implementation of the LIFE Study have been reported previously. 9 
PA intervention and health education program
Because of publication word limits, full details regarding study interventions are provided in Supplementary Material S1 and have been published previously. 10 
Accelerometry
A triaxial accelerometer (GT3X, Actigraph, Inc., Pensacola, FL) was used to objectively measure sedentary and PA time. 4 PA was divided into three incremental intensity categories identified according to accelerometer-detected ranges of 100 to 499, 500 to 1,039, and 1,040 or more counts per minute (cpm), as published previously. 11 For the data to be included in this study, participants had to wear the accelerometer on at least 3 days for 10 hours per day in free-living conditions. The present study includes longitudinal data collected from 1,590 LIFE Study participants. Those who did not have valid accelerometry data from at least one visit were removed from the analysis (n = 45).
Assessment of MMD
The 400-m walk test served as our criterion indicator of MMD, which was defined as the inability to complete the 400-m walk within 15 minutes without help from another person or an assistive device other than a cane (e.g., walker, wheelchair). Participants were instructed to walk at their usual pace for 400 m (10 laps of a 20-m course defined using two cones). The maximum time allowed for the test was 15 minutes, without sitting and without the help of another person. Participants were allowed to stop and stand to rest for up to 1 minute and could use a cane, but they were not allowed to lean against any object or person to support their weight. Time to complete the 400-m walk was recorded in minutes and seconds and converted to seconds. 1 Participants were scored with persistent major mobility disability (PMMD) when the MMD incident was noted at two consecutive time-points. 1 Death after an initial MMD determination was considered PMMD as well. No participant had MMD at baseline.
Statistical Analysis
Baseline characteristics, including demographic characteristics and self-reported disease history, were summarized using means and standard deviations (SDs) for continuous measures and counts (percentages) for discrete measures according to randomization group. A series of Cox proportional hazards regression models were used to evaluate associations with initial incidence of MMD and PMMD. Seven baseline daily accelerometry measures of interest were included in this analysis one at a time: minutes of activity count less than 100 cpm (per 30 minutes) (for easier interpretation of the coefficients), minutes of activity count of 1,040 cpm or more (per 30 minutes), total activity counts (per 10,000 counts), total step counts (per 500 steps), 30 minutes of peak cadence (per 10 steps/ min), 5-minute bouts (≥5 consecutive minutes of activity count ≥100 cpm), and 10-minute bouts (also ≥ 100 cpm). The interactions between each accelerometry measure and intervention groups were tested to check whether the accelerometry effects were the same in the PA and HE groups. A separate analysis was conducted to explore the effects in the HE group alone, which showed no difference in the current results of this analysis from the PA group. Therefore, we did not divide our cohort according to randomization arm in this analysis (Supplementary  Table S1 ). Considering multiple comparisons, a conservative Bonferroni correction with P < .004 (0.05/(7*2) for seven individual accelerometry measures and two outcomes).
To study how different levels of PA were associated with MMD and PMMD, minutes of activity with 100 to 499 cpm (per 30 minutes), 499 to 1,039 cpm (per 30 minutes), and 1,040 cpm or more (per 30 minutes) were included in a model simultaneously. Because the sum of the minutes within all levels equaled the wear time, to avoid singularity, only three levels were fitted in the model. In addition, the sedentary level (activity minutes of activity count <100 cpm [per 30 minutes]) was highly correlated with the other three activity levels (correlation coefficients >0.85), so it was not selected to be included in the model. Pairwise interactions and the three-way interaction were also tested. To avoid collinearity, the variables used in the interaction terms were centered (variable minus mean of the variable). If the higher-order interaction was not significant, it was removed from the model. Each accelerometry measure was also defined as a time-dependent variable and refitted allowing for it as a time-dependent covariate. Time-varying covariate models used accelerometry data at baseline to predict MMD and PMMD events in the interval from 0 to 6 months, 6-month PA to predict MMD and PMMD events during 6 to 12 months, 12-month PA to predict MMD and PMMD events during 12 to 24 months, and 24-month PA to predict MMD and PMMD events at 24 months and after. Likelihood ratio tests were used to assess statistical significance. All Cox model analyses were performed using R version 3.2.3 (survival package) (Therneau T (2015) A Package for Survival Analysis in S. version 2.38, http:// CRAN.R-project.org/package=survival). Additional analyses included testing of the interaction between each accelerometry measure and randomization and a sensitivity analysis performed to evaluate the influence of prior CVD history on outcomes.
RESULTS
Details of recruitment and baseline characteristics were published previously. 12 The mean age AE SD of included participants was 78.9 AE 5.2, 67.2% were women, 23.6% were racial or ethnic minorities, 35.9% were married, and 63.8% reported having a college education. In general, participants were cognitively intact (modified Mini-Mental State Examination score 91.7 AE 5.4), showed low levels of depressive symptoms (Center for Epidemiologic Studies Depression Scale score 8.5 AE 7.8), and had relatively poor sleep quality (Pittsburgh Sleep Quality Index score 5.9 AE 3.8). Details of MMD and PMMD event rates in the LIFE Study were published previously. 4 Similar results were observed for the cohort in the present study for MMD (32.6%) and PMMD (17. 9%). Additional details regarding participant characteristics are provided in Table 1 . There were no significant interactions between any of these baseline variables and randomized arm (all P > .05).
At baseline, participants wore accelerometers for a mean 7.95 AE 3.24 valid wear days and 837. 
The associations between baseline accelerometry variables and MMD and PMMD rate are shown in Table 2 . Each 30 minutes of sedentary time was associated with a 10% greater rate of MMD. Conversely, every 500 steps taken was associated with a 15% lower rate of MMD and an 18% lower rate of PMMD. Activity of 1,040 cpm or more was not associated with MMD or PMMD after considering multiple comparisons, although the amount of time spent in this level of activity was small. Peak cadence and number of activity bouts of 5 minutes or more were also associated with lower rates of mobility disability.
When fitting different levels of activities (30 min/d of activity 100-499 cpm, 500-1,039 cpm, and ≥1,040 cpm) in the same model, only moderate PA time activity (100-499 cpm) was significantly associated with MMD (hazard ratio (HR) = 0.89), and no levels of activities were associated with PMMD (Table 3 ). None of the tested interactions reached significance in the final model, although the interaction between activity of 500 to 1,039 cpm and 1,040 cpm or greater was significantly associated with MMD in Models 1 to 3 (Model 4: P = .10). Associations between time-dependent accelerometry (collected at 0, 6, 12, and 24 months) variables and incident MMD and PMMD are shown in Supplementary  Tables S2 and S3 . The results are consistent with the results for baseline associations. In particular, every 30 minutes spent sedentary was associated with 17% greater rates of MMD and PMMD. Most indices of PA were also significantly associated with rates of MMD and PMMD. When fitting differing levels of activity jointly, minutes per day at 100 to 499 cpm PA level was negatively associated with MMD and PMMD (both HR = 0.81) after adjusting for 500 to 1,039 cpm, 1,040 cpm ore more, and covariates. Minutes per day of 1,040 cpm or more was also negatively associated with MMD (HR = 0.52) and PMMD (HR = 0.48), after adjusting for lower levels of activities (100-499 and 500-1,039 cpm).
DISCUSSION
The primary finding of this study is that accelerometrybased indices of PA and sedentary behavior were associated with rates of MMD and PMMD in mobility-limited older adults. Specifically, every 30-minute increase in sedentary time was significantly associated with a higher rate of MMD. These findings were consistent when using a single baseline assessment or serial longitudinal assessments over a 24-month period.
The findings of the present study expand upon the main LIFE Study results by demonstrating that a single baseline assessment of PA can be predictive of subsequent MMD events. This shows the potential added value of accelerometry in this older population as a clinical tool for assessing PA levels. Individual counseling based on accelerometryderived PA levels may reduce inactivity levels and further reduce risk of MMD. For example, average number of steps per day was associated with a 15% lower event rate of MMD and an 18% lower rate of PMMD in LIFE Study participants. Increasing daily number of steps may be a motivating and easily achievable outcome that could decrease risk of MMD in older adults with mobility impairments. These results are particularly notable given some concerns that researchers in the field have expressed related to the reliability and sensitivity of such accelerometryderived information in adults with slowed or uneven gait or similar mobility impairments. 13 The present results showed that PA levels of 100 to 499 cpm were associated with a significantly lower (11%) MMD event rate. Higher levels of PA (500-1,039, ≥1,040) were not associated with lower MMD and PMMD event rates. Although the current PA guidelines suggest that higher levels of PA (moderate to vigorous PA (MVPA)) be achieved for health benefits (760-1,952 cpm), 14 these findings suggest that more-achievable light PA (100-499 cpm) can have important effects on MMD.
The accelerometry cut-points used in the present study differ somewhat from some others previously reported in the literature. For instance, one report of adults aged 65 and older from the National Health and Nutrition Examination Survey (NHANES) used more than 1,952 cpm for MVPA, 760 to 1,951 cpm for light PA, and 101 to 759 cpm for very light PA. 15 Other authors used a threshold of 760 cpm to characterize MVPA, 16 although they authors that the 1,952-cpm threshold used for MVPA determination resulted in fewer participants meeting these levels of PA than with a 760-cpm MVPA threshold. 16 Another study reported that 40% of older adults were unable to engage in MVPA using a 1,041-cpm threshold to characterize MVPA. 17 There is a lack of clarity regarding appropriate count thresholds that will not over-or underestimate MVPA in older adults of varying age groups and mobility impairment levels. Based on our results, for individuals who are not able to achieve MVPA intensities, recommending lower levels of PA intensity (up to 500 cpm) that are more achievable and effective in lowering incident risk of MMD may increase involvement of moderately functioning older adults in PA interventions and further lower the risk of physical disability.
In addition to tracking activity, accelerometry provides important information regarding inactivity and sedentary behavior. Higher levels of sedentary time are independently associated with greater metabolic dysfunction, physical disability, and mortality. 16, 18 LIFE Study participants spent 77% of their waking hours being sedentary (Supplementary Table 3 ). This is in agreement with other studies of older adults. [19] [20] [21] The present analysis showed that lower levels of sedentary time were associated with lower (10%) MMD event rates. Similarly, another study showed that participants in NHANES with mobility disability accumulated not only the highest volumes of sedentary time per day (69%), but also more sedentary time in longer sedentary bouts and shorter active bouts than those without mobility disability. 15 It has been shown that regular interruption of sedentary time, even with light-intensity activity, is associated with health benefits in some populations. 16 Therefore, tracking of PA and sedentary time, in the form of bouts and total time, may have relevance for predicting MMD. Moreover, PA guidelines for older adults should focus not merely on increasing PA levels, but also on reducing total daily sedentary time in older adults to prevent incident MMD. It is important that health professionals and patients understand these relative benefits so that the older adults can be counseled according to mobility and health status.
This study had a few limitations worth noting. First, the lack of general agreement on PA intensity thresholds in this population is a limiting factor in generalizing these results to other groups of older adults. Additionally, causal interferences may not be drawn from this longitudinal study. Another aspect of the study that warrants discussion is the inclusion of the PA group in our primary analysis. This approach incorporates a group that was specifically given an intervention designed to affect the primary risk factor. Our rationale for this approach was to capitalize upon all of the data available in the trial and to evaluate the effects of accelerometry in individuals who did and did not engage regularly in PA as might be seen in everyday settings. Analyses including an interaction term for randomized arm and analyses conducted separately within groups did not reveal an indication of any differences in the utility of accelerometry between groups. Still, the potential confounding of this approach should be noted.
In conclusion, this study has several important strengths, including the multisite clinical trial study design, large sample size, and multimodal PA data collection (according to accelerometry and self-report). These results indicate that accelerometry-based baseline and longitudinal assessment of PA and sedentary time levels are useful for assessing event rates of MMD and PMMD in mobility-limited older adults. Number of steps per day and time spent in lower levels of activity (e.g., 100-499 cpm) were significantly associated with lower MMD event rates. Therefore, public health messages encouraging increases in low-level activity and decreases in sedentary time may be fruitful in reducing mobility disability in this population. Moreover, accelerometry may be a good clinical tool for assessing and preventing MMD risk in older adults, which may help in better counseling older individuals on PA levels needed to prevent MMD. Further studies are warranted to support these findings are further refine recommendations for accelerometry activity thresholds.
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